Yadav, V.; Jobe, N.; Satapathy, S.R.; Mohapatra, P.; Andersson, T.
Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. Cancers 2022, 14, 6077.
https://doi.org/10.3390/cancers14246077
AMA Style
Yadav V, Jobe N, Satapathy SR, Mohapatra P, Andersson T.
Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. Cancers. 2022; 14(24):6077.
https://doi.org/10.3390/cancers14246077
Chicago/Turabian Style
Yadav, Vikas, Njainday Jobe, Shakti Ranjan Satapathy, Purusottam Mohapatra, and Tommy Andersson.
2022. "Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling" Cancers 14, no. 24: 6077.
https://doi.org/10.3390/cancers14246077
APA Style
Yadav, V., Jobe, N., Satapathy, S. R., Mohapatra, P., & Andersson, T.
(2022). Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. Cancers, 14(24), 6077.
https://doi.org/10.3390/cancers14246077